Conclusion Of A Non Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredient Naloxegol Atc A06Ah03 Obo For The Period 01 08 2024 31 07 2026

Deadline: 05 Jun 2026

Germany

Ref. No.: 6373588

EMD:Ref Document

Bid Value: Ref Document

2 Days Left

Conclusion Of A Non Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredient Bimatoprost Timolol Exclusively Edo Atc S01Ed62 Obo For The Period 01 08 2024 31 07 2026

Deadline: 05 Jun 2026

Germany

Ref. No.: 6373231

EMD:Ref Document

Bid Value: Ref Document

2 Days Left

Open House Drug Rebate Agreements Ustekinumab Atc L04Ac05

Deadline: 05 Jun 2026

Germany

Ref. No.: 6373143

EMD:Ref Document

Bid Value: Ref Document

2 Days Left

Medicines Containing The Active Ingredient Lanthanum Iii Carbonate Atc V03Ae03 In The Dosage Form Chewable Tablets

Deadline: 31 May 2026

Germany

Ref. No.: 6371060

EMD:Ref Document

Bid Value: Ref Document

-3 Days Left

Conclusion Of A Non Exclusive Discount Agreement According To Section 130A Paragraph 8 Sgb V For The Active Ingredient Ustekinumab Atc L04Ac05 Obo For The Period 01 08 2024 31 07 2025 Plus Extension Option 1X12 Months

Deadline: 05 Jun 2026

Germany

Ref. No.: 6369929

EMD:Ref Document

Bid Value: Ref Document

2 Days Left

Conclusion Of A Non Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredient Pegvisomant Atc H01Ax01 Obo For The Period 01 08 2024 31 07 2026

Deadline: 05 Jun 2026

Germany

Ref. No.: 6369748

EMD:Ref Document

Bid Value: Ref Document

2 Days Left

Conclusion Of A Non Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredient Fesoterodine Atc G04Bd11 Obg For The Period 01 08 2024 31 07 2026

Deadline: 05 Jun 2026

Germany

Ref. No.: 6369364

EMD:Ref Document

Bid Value: Ref Document

2 Days Left

Medicines Containing The Active Substance Guselkumab Atc L04Ac16

Deadline: 31 May 2026

Germany

Ref. No.: 6368757

EMD:Ref Document

Bid Value: Ref Document

-3 Days Left

Qualification System For Cables And Wires

Deadline: 31 Dec 2099

Germany

Ref. No.: 6368089

EMD:Ref Document

Bid Value: Ref Document

26874 Days Left

Conclusion Of A Non Exclusive Discount Agreement According To Section 130A Paragraph 8 Sgb V For The Active Ingredient Lisdexamfetamine Atc N06Ba12 Obg For The Period 01 08 24 31 07 25 Plus Extension Option 1X12 Months

Deadline: 05 Jun 2026

Germany

Ref. No.: 6367992

EMD:Ref Document

Bid Value: Ref Document

2 Days Left

Open House Biologics Discount Agreements 2024 08 Darbepoetin Alfa

Deadline: 01 Aug 2026

Germany

Ref. No.: 6352753

EMD:Ref Document

Bid Value: Ref Document

59 Days Left

Army Rapid Capabilities And Critical Technologies Office Rccto Broad Agency Announcement Baa

Deadline: 18 Jun 2029

United States

Ref. No.: 6347893

EMD:Ref Document

Bid Value: Ref Document

1111 Days Left

2024 Department Of Homeland Security Dhs Directorate Of Science And Technology S T Long Range Broad Agency Announcement Lrbaa 24 01

Deadline: 31 May 2029

United States

Ref. No.: 6346114

EMD:Ref Document

Bid Value: Ref Document

1093 Days Left

Dla Emergent Iv Research And Development Program

Deadline: 12 Jun 2027

United States

Ref. No.: 6345486

EMD:Ref Document

Bid Value: Ref Document

374 Days Left

Conclusion Of A Non Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredient Omalizumab Atc R03Dx05 Obo For The Period 01 08 2024 31 07 2025 Plus Extension Option 1X12 Months

Deadline: 05 Jun 2026

Germany

Ref. No.: 6344888

EMD:Ref Document

Bid Value: Ref Document

2 Days Left

Filter Your Search

Tenders by Countries

Browse Popular Sectors

Projects by Regions

Funding Agency

Support

CONTACT DETAILS

Filter Your Search

FREE Trial plan for all new users!